CoChat

Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

1. The selectivity of eight chemical inhibitors has been extensively evaluated with 10 cDNA-expressed human cytochrome P450 isoforms (CYP). The results indicate that sulphaphenazole, quinidine and alpha-naphthoflavone are selective inhibitors of CYP2C9 (IC50 = 0.5-0.7 microM), CYP2D6 (0.3-0.4 microM) and CYP1A (0.05-5 microM) respectively on the basis of the IC50, which are much lower than those of other P450 isoforms (> 10-fold). 2. Ketoconazole exhibited potent inhibition of both CYP3A4-catalysed metabolism of phenanthrene, testosterone, diazepam (IC50 = 0.03-0.5 microM) and CYP1A1-catalysed deethylation of 7-ethoxycoumarin (0.33 microM). The selectivity of ketoconazole for other P450s was highly related to the concentration used. 3. Diethyldithiocarbamate, orphenadrine and furafylline were shown separately to be less selective inhibitors of CYP2E1, CYP2B6 and CYP1A isoforms by a broad range of IC50 that overlap those observed with other P450 isoforms. 4. Furafylline, quinidine and alpha-naphthoflavone activated CYP3A4-catalysed phenanthrene metabolism by 1.7-, 2- and 15-fold respectively. 5. The selectivity of orphenadrine and ketoconazole was further examined by using inhibitory monoclonal antibodies (MAb). Inhibitory MAb specific for the individual P450 isoforms may be of greater value than chemical inhibitors.

Overview

Integrity signals

Registry

Crossref · 10.1080/004982500237541

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Research works printed but not linked: 11

  1. BOURRIE M., 1996, Journal of Pharmacology and Experimental Therapeutics, 277, 321
  2. CHANG T. K., 1993, Cancer Research, 53, 5629
  3. GELBOIN H. V, 1993, Pharmacological Review, 45, 413
  4. HASEGAWA T., 1994, D rug Metabolism and Disposition, 22, 916
  5. HEYN H., 1996, Drug Metabolism and Disposition, 24, 948
  6. NEWTON D. J., 1995, Drug Metabolism and Disposition, 23, 154
  7. SAI Y., 1999, Pharmacogentics, 9, 229
  8. SANDERINK G. J., 1997, Journal of Pharmacology and Experimental Therapeutics, 282, 1465
  9. SPRACKLIN D. K., 1996, Drug Metabolism and Disposition, 24, 976
  10. STEVENS J. C., 1997, Journal of Pharmacology and Experimental Therapeutics, 282, 1389
  11. YUN C. H., 1992, Cancer Research, 52, 1868

Cited by

See all 142

Metadata

Authors
Sai, Y., Dai, R., Yang, T. J., Krausz, K. W., Gonzalez, F. J., Gelboin, H. V., & Shou, M.
Affiliations
National Institutes of Health (US)
Venue
Xenobiotica
Published
2000-01
Volume
30
Issue
4
Pages
327-343
ISSN
  • 0049-8254 (ISSN-L)
  • 1366-5928
OpenAlex
W2043368734
Cited by
138
References
35
Citations by year
2026: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 2 · 2018: 3 · 2017: 2 · 2016: 4 · 2015: 3 · 2014: 4 · 2013: 3 · 2012: 5
FWCI
11.18
Type
journal article
Language
en
Open access
closed
Locations
  • Xenobiotica (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
cytochrome P450 inhibitors, inhibitor selectivity, ketoconazole, quinidine, alpha-naphthoflavone, diethyldithiocarbamate, orphenadrine, furafylline, CYP3A4, CYP2C9, CYP2D6, CYP1A, CYP2E1, CYP2B6, testosterone metabolism, diazepam metabolism, enzyme induction
MeSH terms
Enzyme Inhibitors, Humans, Isoenzymes, Substrate Specificity, DNA, Complementary, Cytochrome P-450 Enzyme Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450. https://app.cochat.ai/papers/10.1080/004982500237541
The paper
Sai, Y., Dai, R., Yang, T. J., Krausz, K. W., Gonzalez, F. J., Gelboin, H. V., & Shou, M. (2000). Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450. Xenobiotica. https://doi.org/10.1080/004982500237541

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.